Ticker Details
Eton Pharmaceuticals, Inc. Common Stock
IPO Date:	November 13, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$480.84M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 2.67%
Avg Daily Range (30 D):	$0.29 | 1.82%
Avg Daily Range (90 D):	$0.30 | 1.79%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.2M
Avg Daily Volume (90 D):	.21M

Trade Size
Avg Trade Size (Sh.):	110
Avg Trade Size (Sh.) (30 D):	58
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	82
Avg Institutional Trade:	$1.61M
Avg Institutional Trade (30 D):	$1.04M
Avg Institutional Trade (90 D):	$1.03M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.99M
Avg Closing Trade (30 D):	$1.02M
Avg Closing Trade (90 D):	$1.03M
Avg Closing Volume:	171K

News

May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals

May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals

Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals

Apr 29, 2024 @ 8:30 PM Eton Pharmaceuticals to Report First Quarter 2024 ... Source: Eton Pharmaceuticals

Mar 22, 2024 @ 6:00 AM Eton Pharmaceuticals Announces Acquisition of PKU... Source: Eton Pharmaceuticals

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.26	$-.07	$-.1
Diluted EPS		$-.07
Revenue	$70.32M	$22.46M	$18.93M
Gross Profit	$36.12M	$7.86M	$11.92M
Net Income / Loss	$-6.68M	$-1.93M	$-2.59M
Operating Income / Loss	$-2.68M	$-1.36M	$-1.48M
Cost of Revenue	$34.2M	$14.6M	$7M
Net Cash Flow	$16.86M	$22.19M	$M
PE Ratio